Table F.4 Proportion of tested Campylobacter jejuni and C. coli isolates from human cases associated with travel, domestic cases and cases with unknown travel information by country in 2020
| Country | Total C. jejuni & C. coli tested | Travel‐associated | Domestic | Unknown |
|---|---|---|---|---|
| N | % | % | % | |
| Austria | 437 | 0.0 | 89.2 | 10.8 |
| Cyprus | 23 | 0.0 | 0.0 | 100.0 |
| Denmark | 254 | 13.4 | 86.6 | 0.0 |
| Estonia | 277 | 0.0 | 59.6 | 40.4 |
| Finland | 1,465 | 0.0 | 0.0 | 100.0 |
| France | 7,539 | 0.0 | 0.0 | 100.0 |
| Italy | 93 | 1.1 | 18.3 | 80.6 |
| Luxembourg | 226 | 0.0 | 0.0 | 0.0 |
| Malta | 172 | 0.0 | 0.0 | 100.0 |
| Netherlands | 1,390 | 0.0 | 0.0 | 100.0 |
| Poland | 36 | 0.0 | 97.2 | 2.8 |
| Portugal | 265 | 0.0 | 100.0 | 0.0 |
| Slovakia | 1,026 | 0.0 | 100.0 | 0.0 |
| Slovenia | 811 | 0.9 | 52.0 | 47.1 |
| Spain | 24 | 0.0 | 100.0 | 0.0 |
| Sweden | 370 | 10.8 | 87.8 | 1.4 |
| Total (MSs 16) | 14,408 | 0.6 | 20.1 | 79.4 |
| Iceland | 90 | 15.6 | 74.4 | 10.0 |
| Norway | 327 | 16.5 | 59.6 | 23.9 |
MSs: Member States; N: number of isolates tested.